Clinical Trials

Showing trials with last updates posted in 2022.

NCT04972253 | WITHDRAWN | PHASE1
0 participants

Phase I BLASST-3 Trial

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-10
Start Date:
2021-12-23
Completion:
2022-12-31
Conditions
  • Bladder Transitional Cell Carcinoma
  • Bladder Cancer
  • Fibroblast Growth Factor Receptor
Interventions
  • DRUG
No Results Yet
NCT04639102 | COMPLETED | NA
72 participants

Practical Alternative to Hospitalization

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-10
Start Date:
2021-02-09
Completion:
2021-07-02
Conditions
  • Emergency Department
  • Health, Subjective
  • Health Care Utilization
Interventions
  • OTHER
No Results Yet
NCT04489420 | TERMINATED | PHASE1
3 participants

Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

Study Type:
INTERVENTIONAL
Last Updated:
2022-08-10
Start Date:
2020-10-01
Completion:
2021-08-10
Conditions
  • Astrocytoma, Grade IV
  • Giant Cell Glioblastoma
  • Glioblastoma Multiforme
  • Cyclophosphamide
  • Immunosuppressive Agents
  • Immunologic Factors
  • Physiological Effects of Drugs
  • Molecular Mechanisms of Pharmacological Action
  • Antiviral Agents
  • Anti-infective Agents
  • Analgesics, Non-narcotic
  • Analgesics
  • Sensory System Agents
  • Peripheral Nervous System Agents
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page